Back to Two Sigma Investments, LP Two Sigma Investments, LP

PRQRPRQR

Showing 8 of 31 quarters

Position history for Two Sigma Investments, LPTwo Sigma Investments, LP's holdings in ProQR Therapeutics N.V.

Yes. Two Sigma Investments holds 1,138,715 shares of PRQR (ProQR Therapeutics), worth $2.1M, as of its Q2 2026 13F filing. It increased the position by 219,858 shares (+23.9%) from Q1 2026. Two Sigma Investments has held PRQR since Q1 2022, across 18 quarterly 13F filings.

Current Value

$2.1M

Current Shares

1.1M

Total Value Change

+$2M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+23.9%
$2.1M0.0%$1.86
32
2026-Q1
Increased
918,857
+9.5%
$1.5M0.0%$1.62
28
2025-Q4
Increased
839,384
+101.2%
$1.7M0.0%$2.02
41
2025-Q3
Increased
417,300
+86.3%
$888,8490.0%$2.13
39
2025-Q2
Decreased
224,040
-25.8%
$457,0420.0%$2.04
0
2025-Q1
Decreased
301,912
-21.2%
$401,5430.0%$1.33
0
2024-Q4
Increased
383,134
+512.8%
$1M0.0%$2.65
40
2024-Q3
Decreased
62,520
-9.3%
$113,7860.0%$1.83
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used